BUZZ-U.S. Stocks on the Move-Corinthian, Markit, Cellular Biomedicine
(For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for more market insights, including options activity, ; for the Day Ahead newsletter, link.reuters.com/mex49s; for the Morning News Call newsletter, link.reuters.com/nex49s) U.S. stocks were little changed on Thursday, after four straight days of gains sent the S&P 500 to a fresh record high, as economic data was not enough to entice investors to push equities higher. The Dow Jones industrial average was down 0.14 percent at 16,882.84 and the S&P 500 was down 0.07 percent at 1,955.67.
** CORINTHIAN COLLEGES INC, $0.315, -62.94 pct
The for-profit education provider said it may not be able to continue as a going concern after the U.S. Department of Education delayed reimbursements. The department has increased the period in which Corinthian is refunded some disbursements to 21 days from 24-72 hours, Corinthian said in a regulatory filing. (1.usa.gov/1qvpC6z)
** ALDEYRA THERAPEUTICS INC, $7.9, +18.09 pct
Aegis Capital Corp started coverage of the biotechnology company with a "buy" rating. Analysts said Aldeyra has the potential to pursue lead rare skin disorder drug for additional skin-related uses. The company also appointed Stephen Tulipano chief financial officer.
** SENOMYX INC, $9.34, +11.86 pct
** Craig-Hallum started coverage of the flavor ingredients maker's shares with a "buy" rating, according to StreetInsider.com. Craig-Hallum set a price target of $16.50 on the stock, according to Benzinga.com. Continued...